¥2,164.00 ($13.71)

-15.00 (-0.69%)

Weekly Expected Move ±5.7%

¥1931 ¥2055 ¥2179 ¥2303 ¥2427

JPX · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 33 · ¥52.7B mcap · 7M float · 2.13% daily turnover

Revenue

$18.6B +11.8% ▲

4Y CAGR: +27.4%

Gross Profit

$14.7B +11.6% ▲

4Y CAGR: +27.9%

Operating Income

$5.9B +11.8% ▲

4Y CAGR: +55.0%

Net Income

$3.8B -5.3% ▼

4Y CAGR: +154.6%

EPS (Diluted)

$154.40 -5.3% ▼

4Y CAGR: +153.1%

EBITDA

$7.9B +12.3% ▲

4Y CAGR: +36.2%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$7.1B	$10.7B	$13.5B	$16.7B	$18.6B
YoY Growth	+0.0%	+51.6%	+26.2%	+23.2%	+11.8%
Cost of Revenue	$1.6B	$2.5B	$3.0B	$3.5B	$4.0B
Gross Profit	$5.5B	$8.2B	$10.5B	$13.1B	$14.7B
Gross Margin	77.5%	76.6%	77.5%	78.9%	78.7%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$4.5B	$6.0B	$6.7B	$7.8B	$8.7B
Operating Expenses	$4.5B	$6.0B	$6.8B	$7.8B	$8.7B
Operating Income	$1.0B	$2.2B	$3.7B	$5.3B	$5.9B
Operating Margin	14.5%	20.8%	27.4%	32.0%	31.9%
Interest Expense	$615M	$921M	$409M	$421M	$338M
Income Before Tax	$515M	$1.3B	$3.3B	$4.9B	$5.6B
Tax Expense	$328M	$713M	$932M	$917M	$1.8B
Net Income	$90M	$292M	$2.2B	$4.0B	$3.8B
Net Margin	1.3%	2.7%	16.4%	24.0%	20.3%
EPS (Diluted)	$3.76	$25.04	$108.03	$163.09	$154.40
EBITDA	$2.3B	$3.6B	$5.2B	$7.0B	$7.9B
Shares Outstanding	24M	24M	21M	24M	25M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$3.8B	$4.6B	$4.2B	$4.7B	$4.5B	$5.2B	$4.9B	$5.4B
Cost of Revenue	$784M	$970M	$857M	$1.0B	$908M	$1.2B	$1.0B	$1.2B
Gross Profit	$3.0B	$3.6B	$3.3B	$3.7B	$3.6B	$4.0B	$3.9B	$4.2B
Gross Margin	79.3%	78.8%	79.6%	78.6%	79.8%	77.3%	79.4%	77.9%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$1.8B	$2.2B	$2.0B	$2.2B	$2.2B	$2.4B	$2.3B	$2.4B
Operating Expenses	$1.8B	$2.2B	$2.0B	$2.2B	$2.2B	$2.4B	$2.3B	$2.4B
Operating Income	$1.2B	$1.4B	$1.3B	$1.6B	$1.4B	$1.6B	$1.6B	$1.8B
Operating Margin	31.1%	30.7%	31.2%	33.2%	31.7%	31.5%	32.9%	33.6%
Interest Expense	$74M	$73M	$80M	$81M	$89M	$88M	$111M	$84M
Income Before Tax	$1.1B	$1.3B	$1.2B	$1.5B	$1.3B	$1.5B	$1.6B	$1.7B
Tax Expense	$351M	-$239M	$445M	$539M	$438M	$418M	$505M	$565M
Net Income	$746M	$1.6B	$782M	$961M	$908M	$1.1B	$1.1B	$1.2B
Net Margin	19.7%	34.4%	18.7%	20.2%	20.2%	21.7%	22.0%	21.7%
EPS (Diluted)	$30.43	$64.09	$31.92	$39.20	$37.06	$46.22	$43.51	$47.90
EBITDA	$1.6B	$1.9B	$1.8B	$2.0B	$1.9B	$2.1B	$2.1B	$2.3B
Shares Outstanding	24M	25M	25M	25M	24M	24M	25M	25M

5889.T JPX